Evaluating the Pharmacokinetics and Systemic Effects of a Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl)amino] Caprylate in Rats.
Oral administration is the preferred route for drug delivery and its success is highly dependent on a compound's ADME properties, of which, permeability plays a major role. Therefore, permeability enhancers are an attractive area of research in the pharmaceutical industry. Recent data suggest that sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC) is an effective permeability enhancer, yet the pharmacokinetic (PK) and systemic effects of SNAC are poorly understood, specifically its oral bioavailability and systemic effects on distribution, which could influence the safety of certain drugs. To answer these questions, both in vitro and in vivo studies were conducted. Of 3 permeability enhancers (SNAC, 4-CNAB, and 5-CNAC), SNAC was found to have the greatest effect on the absorption of cyanocobalamin in rats. It was also found that SNAC is orally bioavailable (almost 40%) when dosed to rats. Based on these findings, tool compounds were co-dosed in rats to further evaluate the systemic effects of SNAC. Oral co-dosing of SNAC with an intravenous infusion of 2 poorly brain penetrant compounds, quinidine, and gabapentin, did not increase brain ISF: plasma ratio or total brain:plasma ratio for either of these compounds, implying that SNAC is effective only in the intestine at pharmacologically relevant concentrations.
['Chiang|Po-Chang|PC|', 'Deshmukh|Gauri|G|', 'Liu|Jia|J|', 'Nagapudi|Karthik|K|', 'Chen|Jacob Z|JZ|', 'Valle|Nicole|N|', 'Li|Ruina|R|', 'Plise|Emile G|EG|', 'Durk|Matthew R|MR|']
D000284:Administration, Oral D000818:Animals D002210:Caprylates D010539:Permeability D004364:Pharmaceutical Preparations D051381:Rats D012964:Sodium
Pharmacokinetics Permeability Distribution Blood-brain barrier Permeation enhancer(s)